B. Rundqvist et al., INTRACORONARY BLOCKADE OF ANGIOTENSIN-CONVERTING ENZYME IN HUMANS - INTERACTION WITH CARDIAC SYMPATHETIC NEUROTRANSMISSION, Acta Physiologica Scandinavica, 161(1), 1997, pp. 15-22
The present study was designed to identify an interaction between the
renin-angiotensin system and noradrenergic transmission in the human h
eart. It is still under debate whether angiotensin ii facilitates nora
drenaline release in the heart. Clinical studies of congestive heart f
ailure, involving systemic angiotensin-converting enzyme (ACE) inhibit
or administration, have indicated anti-adrenergic effects, without giv
ing a clear mechanistic picture. The influence on cardiac sympathetic
transmission by local intracardiac administration of an ACE inhibitor
has not been determined. Seven angina patients with normal left ventri
cular function, who underwent control coronary angiography after succe
ssful percutaneous transluminal coronary angioplasty were studied. Bas
eline measurements of haemodynamics and total and cardiac noradrenalin
e spillover were followed by handgrip exercise in the absence and pres
ence of intracoronary enalaprilat infusion (0.05 mg min(-1), 1 mL min(
-1)). Baseline total body and cardiac noradrenaline spillover remained
unchanged following intracoronary enalaprilat infusion, being 3745 +/
- 349 and 3896 +/- 257 pmol min(-1), and 148 +/- 56 and 149 +/- 55 pmo
l min(-1), before and after drug administration, respectively. Mean ar
terial pressure, peripheral plasma renin activity and angiotensin II l
evels were also unaffected by enalaprilat infusion. During handgrip ex
ercise procedures, both total body and cardiac noradrenaline spillover
increased substantially, showing no reduction in the presence of intr
acardiac enalaprilat. Direct administration of the ACE inhibitor enala
prilat to the human heart failed to attenuate cardiac sympathetic driv
e during baseline conditions or following cardiac adrenergic activatio
n by handgrip exercise. Thus, in the non-failing heart, without chroni
c adrenergic activation, no angiotensin II-facilitated effect on cardi
ac noradrenaline spillover could be detected.